
By: Rostom Omar, Esq. (Primerio/African Antitrust)
Egypt finally adopts a new merger-control regime that would transform the system from a post-notification to a pre-approval system.
After nearly twenty years of applying Competition Law in Egypt and After several attempts from the Egyptian Competition Authority (ECA) to introduce a pre-merger notifications regime and several discussions with government, the parliament and sectorial regulators; on Dec 4th, 2022 the Egyptian parliament has finally approved the proposal to amend the Law on Protection of Competition and Prohibition of Monopolistic Practices No. 3 of 2005 (ECL).
It is worth mentioning in this regard that Egypt was the only country in the region and one of the few countries in the world whose law was not adopting merger Pre- approval system; at a time when M&As increased significantly in the region during the last few years and in which Egypt occupies an advanced position.
According to article 19 of the ECL (Post notification) the acquisition of shares or assets, or joint venture that results in a change of control of an entity or material influence over such entity should be notified after 30 days of concluding the transaction if the combined turnover of the parties exceeds 100 M EGP. It is not yet clear if the non-controlling minority acquisitions would be included in the new filing requirement…
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas